44% of Russian doctors are ready to take reasonable risks only if their work is assessed by an independent panel of experts, according to a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik.

In 2020, the sales of veterinary drugs in the Russian retail market amounted to RUB 20.3 bln (retail prices, VAT included), which is in monetary terms (rubles) 0.2% lower than in 2019. The growth rate in physical terms (in minimum dosage units, MDU) is -3.4%, with the market volume of 191 bln MDUs.

Between January and September 2020, the total volume of online sales or reservation of medicinal products (pharmaceutical drugs and parapharmaceuticals) in Russia amounted to RUB 95.2 bln (end-user prices, VAT included), which is nearly 9.2% of the market volume. The e-commerce segment in this ranking is represented only by organizations selling medicinal products on a regular basis; these volumes do not include the revenue of gray online businesses supplying original drugs to Russia from other countries, as well as services selling generics unregistered in Russia.

While working with pharmacy associations, manufacturing companies and therefore, customers of marketing activities will inevitably have to face the following issue: some pharmacies cooperate with more than one association, which leads to the duplication of sales in the accounting reports. That, in turn, leads to the problem of fair settlements with associations, which could then result in incorrect planning and accounting distortion between different departments, as well as bring complications when assigning tasks to medical representatives, etc.

Between January and November 2020, Russia produced RUB 450.7 bln worth of pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 17.4% higher than in 2019. The production volume in physical terms (units) amounts to 4.4 bln units, with the growth rate of +6.5%. If calculated in minimum dosage units (MDU), the growth rate is higher (+10.7%) and the production volume is 74.6 bln MDUs.

Between January and October 2020, Russia imported RUB 134.1 bln worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 20% higher than in 2019. The import volume in physical terms (tons) amounted to 12.1 thousand tons, with the growth rate of +12%.

Between January and October 2020, Russia imported RUB 404 bln worth of ready-made pharmaceutical drugs (customs clearance and VAT included), which is in monetary terms (rubles) 29.6% lower than in 2019. That is clearly the high base effect, since back in October 2019 the importers were hard at work, preparing for the launch of the labeling system by actively stocking up the warehouses; the import volumes were 2-3 times higher than usual. The growth rates of the in-bulk import are still positive, although only +2.2%, with the import volume of RUB 110.8 bln.

Between January and September 2020, Russia exported RUB 40.2 bln worth of ready-made pharmaceutical drugs (customs duties included), which is virtually comparable of the total export volume in 2018. The dynamics in monetary terms (rubles) are as high as +23.3%. The export volume in physical terms amounts to 0.83 bln units, with the dynamics of +27.5%.

Between January and October 2020, Russia manufactured RUB 399.1 bln worth of pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 17% higher than in 2019. These dynamics are significantly lower, compared to the dynamics of the period between Q1 and Q3. The dynamics in physical terms are even less promising: +12.4% in units and +15.2% in minimum dosage units (MDU). The production volume in physical terms amounts to 4 bln units, or 68.4 bln MDUs.

It seems that the moment of truth will come to the Russian pharmaceutical retail market next year. After several years of relatively stable development and a number of waves of rush demand in 2020, 2021 may become a period of a most severe crisis, making all the current problems associated with the launch of the labeling system seem like mere trifles.